Company Analysis

Orchestra BioMed Holdings, Inc. (OBIO)

Nasdaq: OBIO · Surgical & Medical Instruments & Apparatus · New Hope, PA · filing with the SEC since 2020
Grade5.1
◀ Past 3.4● Present 4.8▶ Future 7.1
2 est.

Who runs Orchestra BioMed Holdings, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Wong Roderick
Chief Executive Officer. First filing Aug 2020, latest Nov 12, 2026, 3 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
24 people on the record since 2020
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Wong RoderickChief Executive OfficerAug 2020Nov 12, 2026none
Taylor Andrew LawrenceChief Financial OfficerJun 2023Nov 9, 2026none
Hochman David PSee RemarksJan 2023Nov 9, 2026none
Sherman DarrenSee RemarksJan 2023Nov 3, 20266 · $400,000
Aiello JoshuaPrincipal Accounting OfficerJan 2023Aug 28, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Fain Eric SdirectorJan 2023Nov 9, 2026none
Pacitti DaviddirectorMar 2024Nov 9, 2026none
Cleary ChrisdirectorFeb 2025Aug 14, 2026none
Mack John ProsperdirectorJul 2024Aug 14, 2026none
Aryeh JasondirectorJan 2023Jun 25, 2026none
Yanchik Connealy PameladirectorJan 2023Jun 25, 2026none
Owners of more than 10% of a classsales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Rtw Investments, LP10% ownerJan 2023Nov 12, 20261 · $0.00
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton OBIO · research, not advice